APLT - Applied Therapeutics launches stock offering
Applied Therapeutics (NASDAQ:APLT) announced Wednesday its plans to issue shares and accompanying warrants in the underwritten public offering. The clinical stage biopharma company said it intends to use the net proceeds rom this offering for general corporate purposes. SVB Securities is acting as the sole book-running manager for the offering. Earlier (June 3): Applied Therapeutics stock rises on EMA orphan drug status for metabolic disorder drug AT-007
For further details see:
Applied Therapeutics launches stock offering